セロトニンおよびカテコアミン再吸収阻害剤の使用とタコツボ症候群の発症
Biopsychosocial science and medicine
|September 2, 2025
まとめ
特定の抗うつ薬,特にセロトニンおよびカテコアミン再吸収阻害剤は,女性におけるタコツーボ症候群 (TS) のリスクを増加させる可能性があります. この発見は,TSの生存者においてこれらの薬剤を慎重に検討することを示唆しています.
科学分野:
- 心臓病科
- 薬理学について
- 精神科
背景:
- タコツーボ症候群 (TS) は,主に高齢の女性の急性心不全であり,しばしばストレス誘発のカテコラミン上昇によって引き起こされます.
- 以前の症例報告では,TSの発症とセロトニンとカテキオラミンの再吸収阻害剤の使用との関連が示唆されています.
研究 の 目的:
- 精神薬,特にセロトニンとカテコアミン再吸収阻害剤の使用とタコツボ症候群の発症との関連を調査する.
主な方法:
- ニューイングランドの緊急診療所に入院した98人のTS患者と32人の心筋梗塞の対照群 (女性) を対象とした症例対照研究.
- 精神薬の使用は医療記録から抽象化され,関連性を分析するためにロジスティック回帰モデルが採用されました.
主要な成果:
- TSの女性は精神疾患の有病率が高く,入院前に精神薬を使用した可能性が高い.
- カテコアミンまたはセロトニン再吸収阻害剤の投与前使用とTS発症との間に有意な関連性が見られた (OR=3. 39).
- セロトニン・ノルエピネフリン再吸収阻害剤 (SNRI) の使用が,この関連性を引き起こすように見えた.
結論:
- カテコアミンまたはセロトニン再吸収阻害剤は,タコツボ症候群を発症するリスクを高めることを示唆しています.
- 臨床医は,TS患者のこれらの薬の使用を慎重に検討する必要があります.
さらに関連する動画
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
9.0K
12:21Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
15.2K
関連する概念動画
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
563
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
563
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Antidepressant Drugs: Overview
741
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
741
Adrenergic Agonists: Indirect-Acting Agents
1.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.8K
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
